You just read:

Endo Pharmaceuticals Presents New Phase 2 Data Evaluating the Safety and Effectiveness of XIAFLEX® (Collagenase Clostridium Histolyticum) for Dupuytren's Disease Nodules

News provided by

Endo International plc

Sep 30, 2016, 07:30 ET